v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Total revenue $ 799 $ 678 $ 2,345 $ 1,725
Costs of revenue 210 117 657 339
Gross profit 589 561 1,688 1,386
Operating expenses:        
Research and development 796 2,525 4,492 6,889
General and administrative 802 990 2,997 3,313
Sales and marketing 87 259 589 877
Armor exit costs 4,457 4,457
Reduction in force 407 407
Grant and contract expenses 448 401 1,061 942
Total operating expenses 6,997 4,175 14,003 12,021
Loss from operations (6,408) (3,614) (12,315) (10,635)
Other income (expenses):        
Interest expense (9) (15) (2)
Interest income 24 33 66 117
Gain (loss) on disposal of equipment (20) 17 (8) 17
Change in fair value of derivative liabilities 173 374 3,459 5,344
Offering costs of derivative liabilities (550) (786)
Other income, net 1 34 7
Total other income (expense), net 169 424 2,986 4,697
Net loss before income taxes (6,239) (3,190) (9,329) (5,938)
Provision for income taxes
Net loss (6,239) (3,190) (9,329) (5,938)
Deemed dividend related to convertible preferred stock (26)
Net loss attributable to common stockholders $ (6,239) $ (3,190) $ (9,329) $ (5,964)
Net loss per share – basic and diluted        
Basic – net loss $ (6.96) $ (151.61) $ (17.30) $ (336.99)
Basic – deemed dividend on conversion of preferred stock (1.48)
Basic – attributable to common stockholders (6.96) (151.61) (17.30) (338.47)
Diluted – net loss (6.96) (161.21) (19.59) (605.90)
Diluted - deemed dividend on conversion of preferred stock (1.47)
Diluted – attributable to common stockholders $ (6.96) $ (161.21) $ (19.59) $ (607.37)
Weighted average common shares outstanding:        
Basic 896,305 21,040 539,252 17,621
Diluted 897,323 21,996 656,468 17,642
Product [Member]        
Total revenue $ 367 $ 168 $ 1,054 $ 643
Grant and Contract [Member]        
Total revenue $ 432 $ 510 $ 1,291 $ 1,082

Source